“The groups of people most affected by COVID-19 and the groups affected by HIV are slightly different, but the bottom line is that inequalities have exacerbated both pandemics, and I think a lot can be learned from them,” says Adeeba Kamarulzaman, professor of infectious diseases at the University of Malaya in Kuala Lumpur, Malaysia,...
In her presentation at WCN’22, Dr. Mariam Priya Alexander, a pathologist at the Mayo Clinic in Minnesota, USA, will describe advances in pathology helping to diagnose glomerular disease, which accounts for approximately 16% of chronic kidney disease (CKD). Dr. Alexander’s research interests include the application of ‘omics and mass cytometry to expand the understanding of...
Dialysis and transplantation are the main treatments for chronic kidney disease (CKD), but accessing those treatments is not always straightforward for patients in rural areas. CKD patients in rural and remote communities encounter many barriers to accessing care and have a higher risk of mortality than those in urban areas. In her talk at WCN’22, Nicki...
Diet is crucial to general health and well-being, but to what extent can we use food to treat and prevent kidney problems? At WCN‘22, this will be the question addressed by Peter Stenvinkel, professor and senior lecturer in the department of renal medicine at the Karolinska Institutet, Stockholm, Sweden. Professor Stenvinkel and colleagues are conducting...
Dr. Shaifali Sandal is a transplant nephrologist and assistant professor at the McGill University Health Center, Montreal, Canada. Her research focuses on improving living donor kidney transplantation (KT) and re-transplantation rates. In patients with kidney failure, transplantation is usually the best therapeutic option. It offers better survival rates and quality of life than dialysis. Economic...
The ISN collaborated with the Dialysis Outcomes and Practice Patterns Study on a web survey assessing the impact of the COVID-19 pandemic on hemodialysis centers. Using a combined approach of random sampling and open invitation, researchers collected data between March 2020 and March 2021 from 412 centers in 78 countries across all ten ISN regions....
The ISN Video Abstract Series is a new initiative by the @ISNeducation Social Media Team showcasing key articles from ISN Journals on social media platforms. Watch the latest episodes on the ISN Academy: A Mathematical Estimation of the Physical Forces Driving Podocyte Detachment Combination Treatment with Rituximab, Low-Dose Cyclophosphamide and Plasma Exchange for Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Dear ISN Community, It was an honor to take up my ISN Presidency at the Virtual WCN’21, the first virtual congress in ISN’s history, conducted successfully despite an incredibly challenging global environment. The innovative WCN'21 virtual platform demonstrated the ISN's commitment to global inclusion, a key theme throughout the year. Indeed, the ISN firmly believes that...
As an NBA Champion and Olympic gold medalist, retired professional basketball player Alonzo Mourning recognizes the potential his high profile has to inspire others. At the height of his basketball career, Mr. Mourning was diagnosed with focal segmental glomerulosclerosis (FSGS), a rare and incurable genetic kidney disease with the potential to derail his career and...
The traditional large clinical trial, where participants are individually randomized to receive single agents or placebo, continues to hold a central place in nephrology, but the benefits of other trial designs are emerging. Professor Meg Jardine is director of the NHMRC Clinical Trials Centre and kidney health research team at the University of Sydney, Australia....
